Универсальное антитело: прорыв в борьбе с коронавирусом в НИЦЭМ им. Н. Ф. Гамалеи

Scientists have found a solution capable of recognizing all variants of SARS-CoV-2

In a world where the coronavirus continues to mutate, scientists from the National Research Center for Epidemiology and Microbiology named after N.F. Gamaleya have made an important discovery: they have discovered a universal antibody capable of recognizing all known variants of SARS-CoV-2. This discovery could be a real breakthrough in the fight against the pandemic.

Map of people infected with coronavirus, archive photo<br>
Map of people infected with coronavirus, archive photo<br>
This will be such a universal antibody, which, at least for today, will recognize from "Wuhan" to the very latest variants of the SARS-CoV-2 virus
Denis Logunov, Deputy Director of the Gamaleya Center

According to him, the antibody is already ready for clinical trials. Thanks to the innovative phage display technology, scientists were able to identify evolutionarily conserved antibodies that act on various parts of the S protein of the virus. This means that the new antibody can effectively resist both the original variant of the virus from Wuhan and its subsequent mutations.

In addition, researchers are working on new vaccine platforms and technologies that can significantly improve the protection of the population. This discovery not only inspires hope, but also emphasizes the importance of scientific research in the fight against global threats.

Read more on the topic:

Two vaccines against HIV infection have been developed in Russia

Clinical trials of the world's first combined vaccine against coronavirus and influenza have begun in the Russian Federation

More than 70 million flu vaccines will be produced at Rostec

Now on home